StockNews.AI
ALGN
StockNews.AI
111 days

Align Technology Announces First Quarter 2025 Financial Results

1. Align Technology's Q1'25 total revenues declined 1.6% sequentially and 1.8% year-over-year. 2. Financial results might impact investor sentiment and stock performance for ALGN.

+1.98%Current Return
VS
+0.76%S&P 500
$173.304/30 04:26 PM EDTEvent Start

$176.7405/01 11:08 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

The decline in revenues indicates struggling demand, reminiscent of past performance declines. Historical analysis shows stock prices typically suffer when revenue contracts persistently.

How important is it?

Q1 earnings directly affect ALGN's stock, making this information highly relevant for investors.

Why Short Term?

Immediate investor reactions will likely respond to quarterly results; longer-term impacts depend on recovery strategies.

Related Companies

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'25"). Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year. Q1'25 total revenues were unfavorably im.

Related News